234 related articles for article (PubMed ID: 36702537)
21. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.
Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
Scand J Gastroenterol; 2019 Jan; 54(1):55-63. PubMed ID: 30700170
[TBL] [Abstract][Full Text] [Related]
22. Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study.
Seishima R; Okabayashi K; Ikeuchi H; Uchino M; Futami K; Noguchi T; Ohge H; Iseki Y; Watanabe K; Itabashi M; Okamoto K; Toiyama Y; Ogino T; Nakamura M; Yamada K; Wakai T; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Ishida F; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Yamamoto S; Hanai T; Maemoto A; Arakaki J; Komori K; Akagi Y; Shida D; Yamaguchi S; Matsuda K; Maeda K; Noake T; Nezu R; Sasaki S; Hasegawa J; Sunami E; Kanemitsu Y; Katsumata K; Uehara K; Kiyomatsu T; Suto T; Kazama S; Yamada T; Goi T; Ishihara S; Ajioka Y; Sugihara K
Am J Gastroenterol; 2023 Jul; 118(7):1248-1255. PubMed ID: 36622356
[TBL] [Abstract][Full Text] [Related]
23. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
25. No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study.
Jairath V; Hokkanen SRK; Guizzetti L; Boxall N; Campbell-Hill S; Patel H
Aliment Pharmacol Ther; 2019 Aug; 50(4):416-424. PubMed ID: 31298421
[TBL] [Abstract][Full Text] [Related]
26. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
Han M; Jung YS; Cheon JH; Park S
J Gastroenterol Hepatol; 2019 Jul; 34(7):1166-1174. PubMed ID: 30672608
[TBL] [Abstract][Full Text] [Related]
27. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
28. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
[TBL] [Abstract][Full Text] [Related]
29. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
30. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study.
Agrawal M; Christensen HS; Bøgsted M; Colombel JF; Jess T; Allin KH
Gastroenterology; 2022 Dec; 163(6):1547-1554.e5. PubMed ID: 35952799
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
[TBL] [Abstract][Full Text] [Related]
32. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
[TBL] [Abstract][Full Text] [Related]
33. Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea.
Kim JW; Song HJ; Boo SJ; Kim HU; Kang KS; Na SY
Korean J Gastroenterol; 2023 Jun; 81(6):243-252. PubMed ID: 37350519
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology, validation, and clinical characteristics of inflammatory bowel disease: the ABIS birth cohort study.
Östensson M; Björkqvist O; Guo A; Størdal K; Halfvarson J; Mårild K; Ludvigsson J
BMC Gastroenterol; 2023 Jun; 23(1):199. PubMed ID: 37291531
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
36. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
[TBL] [Abstract][Full Text] [Related]
37. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China.
Zhai H; Liu A; Huang W; Liu X; Feng S; Wu J; Yao Y; Wang C; Li Q; Hao Q; Hu J; Zhang S
BMC Gastroenterol; 2016 Jan; 16():2. PubMed ID: 26754840
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
[TBL] [Abstract][Full Text] [Related]
39. Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizens.
Krarup AL; Larsen L; Nayeb AB; Grøntved S; Paaske Johnsen S; Esbjørn M; Fallingborg J; Nielsen GL; Allin K; Jess T; Olesen AE
Scand J Gastroenterol; 2023 May; 58(5):477-482. PubMed ID: 36356318
[TBL] [Abstract][Full Text] [Related]
40. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE.
Martins KR; Araújo JM; Cruz ÁC; Luiz-Ferreira A
Arq Gastroenterol; 2021; 58(3):377-383. PubMed ID: 34705974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
